Please wait while the transcript is being prepared...
0:00
Hi. I'm Carmen Presti.
I'm an Acute Care
Nurse Practitioner.
I work in the cardiovascular
ICU, the thoracic unit,
which is also lung
transplant and ECMO,
and the general surgery ICU.
I'm going to begin the
discussion today that just is
a basic overview on
the use of mechanical
circulatory support devices.
This will not encompass
all configurations,
but at least we'll give an
introduction to the topic.
0:29
So, here are some
objectives that I
hope to meet by the
end of today's talk.
As you can see,
we're going to be
talking about temporary versus
durable mechanical
circulatory support devices
and indications,
complications,
contraindications as well.
0:47
So, we all know that in the
United States
cardiovascular disease
is the number 1 killer,
but it is also a problem
of pandemic proportions.
Recently, the Heart Failure
Society of America,
the European Society
of Cardiology
and Japanese Heart
Failure Societies
all convened to develop
a universal definition
of heart failure (HF),
which is considered
a clinical syndrome
with symptoms and/or
signs caused by
a structural and/or functional
cardiac abnormality
corroborated by elevated
natriuretic peptides which
indicate obviously fluid
overload status of the heart
and/or objective evidence of
pulmonary or
systemic congestion.
In the United States,
we see that these
numbers are going to be
increasing by 2030 because of
the aging of the
population as well as
advanced levels of
obesity and diabetes,
and that's going to come
along with an increase of
127% estimated in
healthcare costs.
So, this is general
heart failure,
but we're going to
drill down into
advanced heart
failure subsets that
then necessitate mechanical
circulatory support.
